{"id":154090,"date":"2021-01-20T00:54:04","date_gmt":"2021-01-20T05:54:04","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/is-inmune-bio-inc-inmb-a-winner-in-the-biotechnology-industry-investorsobserver\/"},"modified":"2024-08-17T16:13:56","modified_gmt":"2024-08-17T20:13:56","slug":"is-inmune-bio-inc-inmb-a-winner-in-the-biotechnology-industry-investorsobserver","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/is-inmune-bio-inc-inmb-a-winner-in-the-biotechnology-industry-investorsobserver.php","title":{"rendered":"Is INmune Bio Inc (INMB) a Winner in the Biotechnology Industry? &#8211; InvestorsObserver"},"content":{"rendered":"<p><p>A rating of 80 puts INmune Bio Inc (INMB) near the top of the Biotechnology industry according to InvestorsObserver. INmune Bio Inc's score of 80 means it scores higher than 80% of stocks in the industry. INmune Bio Inc also received an overall rating of 64, putting it above 64% of all stocks. Biotechnology is ranked 36 out of the 148 industries.<\/p>\n<p>Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 64 means the stock is more attractive than 64 percent of stocks.<\/p>\n<p>Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.<\/p>\n<p>INmune Bio Inc (INMB) stock is trading at $26.95 as of  10:09 AM on Tuesday, Jan 19, an increase of $2.13, or 8.58% from the previous closing price of $24.82. The stock has traded between  $25.08 and $28.19 so far today. Volume today is low. So far 58,396 shares have traded  compared to average volume of 246,327 shares. <\/p>\n<p>Click Here to get the full Stock Score Report on INmune Bio Inc (INMB) Stock.<\/p>\n<p>Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.<\/p>\n<p>You May Also Like<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Continue reading here:<br \/>\n<a target=\"_blank\" href=\"https:\/\/www.investorsobserver.com\/news\/stock-update\/is-inmune-bio-inc-inmb-a-winner-in-the-biotechnology-industry\" title=\"Is INmune Bio Inc (INMB) a Winner in the Biotechnology Industry? - InvestorsObserver\" rel=\"noopener noreferrer\">Is INmune Bio Inc (INMB) a Winner in the Biotechnology Industry? - InvestorsObserver<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> A rating of 80 puts INmune Bio Inc (INMB) near the top of the Biotechnology industry according to InvestorsObserver. INmune Bio Inc's score of 80 means it scores higher than 80% of stocks in the industry <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/is-inmune-bio-inc-inmb-a-winner-in-the-biotechnology-industry-investorsobserver.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-154090","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/154090"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=154090"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/154090\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=154090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=154090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=154090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}